Advances in Small Molecule Inhibitors for Cancer Inflammation and Autoimmune Diseases
Small molecule inhibitors have emerged as pivotal therapeutic agents in targeting cancer, inflammation, and autoimmune diseases. These compounds are designed to interfere with specific molecular pathways, offering improved efficacy and reduced side effects. This review explores the latest advances in small molecule inhibitors, highlighting key mechanisms, recent clinical developments, and future directions in their application for disease treatment.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-04-04
- DOI
- https://doi.org/10.5281/zenodo.15147735
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00